Delivery Order SPE2DB24D2205-SPE2DB24FDWCH

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,578.00 and a completion date of May 23, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The $3,156.00 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), which is a defense agency. The contract has a completion date of May 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order contract with a ceiling value of $1,052.00. The contract is for the supply of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,578.00, is for the pharmaceutical product "MOUNJARO 10 MG/0.5 ML PEN 0.5ML". The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that provides logistics and acquisition support to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $14,906.00 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on June 24, 2024, with a completion date of June 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The $2,367.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, with an ultimate completion date of June 17, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $6,952.88 firm-fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The $2,035.40 firm-fixed-price delivery order was awarded on May 6, 2024 by the Defense Logistics Agency (DLA), with a completion date of May 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract, valued at $13,087.49, is a Delivery Order from the Defense Logistics Agency (DLA), a defense agency, and has a performance period through May 30, 2025. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $3,500.78, is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen Drug Corp to...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDWCH
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $5,808.54 fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces.

The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/25/24, 9:19 AM